1.Research on the electromyographic signals of orbicularis oculi muscle of rabbit.
Dong-yue XU ; Jing-quan LIU ; Ke-yong LI ; Yu-juan WANG ; Yue-feng RUI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2010;45(11):930-934
OBJECTIVETo study the features of electromyographic signals of orbicularis oculi muscle (OOM) of normal rabbits in various movement states, and to clarify relationships between functional actions of OOM and their electromyographic signals, hoping to obtain information concerning the electromyographic signals controlling OOM as reference for restoring the eye-closing function by artificial facial nerve prosthesis in patients with unilateral peripheral facial palsy.
METHODSThe electromyographic signals were extracted from OOM of normal rabbits by implanted microelectrodes through upper and lower eyelids. Then the features of these electromyographic signals were analyzed in the time domain and the frequency domain.
RESULTSThe peak values of the absolute electromyographic amplitude for natural continuous eye-opening event, natural continuous eye-closing state, natural eye-blinking movement and evoked eye-closing state were (28.8 ± 4.8) µV, (36.0 ± 4.7) µV, (398.8 ± 195.7) µV, and (715.4 ± 249.7) µV, respectively. The peak frequency values of the power spectrum density (PSD) of electromyographic signals for the four modes were (98 ± 17) Hz, (142 ± 22) Hz, (203 ± 58) Hz, and (349 ± 81) Hz, respectively. The electrical activities during the natural continuous eye-opening event and the natural continuous eye-closing state were stable and displayed low amplitudes. During the spontaneous blink state and the evoked eye-closing state, the electromyographic amplitudes markedly increased, and the increased level in the latter state was stronger than that in the former state. When rabbits continuously closed eyes or opened eyes, all of the peak values of the absolute voltage amplitudes were less than 50 µV. The absolute amplitude values of the starting site were between 50 µV and 60 µV during the spontaneous blink and the evoked eye-closing movements. The whole frequency band of the energy of PSD about OOM was between 0 Hz and 500 Hz, and the focus frequency range was between 20 Hz and 350 Hz.In the time domain, the difference was not significant for the electromyographic signals of OOM between the continuous eye-opening state and the continuous eye-closing movement (P > 0.05), but there were statistically significant differences in the other states for their pairwise comparisons (P < 0.05). In the frequency domain, there was no statistically significant difference for the peak frequency of PSD about the electromyographic signals when comparing the continuous eye-opening state with the continuous eye-closing event (P > 0.05). When comparing this item in the other movements with each other, however, the differences were statistically significant (P < 0.05).
CONCLUSIONSOOM relaxes when eyelid keeps continuously opening. The action of eyelid-closing is due to contraction of this muscle. Each state has its own features of the electromyographic signals for OOM, these features can be used as criteria for computers to judge and identify various movement states of OOM. However, it is difficult to distinguish the natural continuous eye-opening event from the natural continuous eye-closing state, based on the features of electromyographic signals in the time and frequency domain.
Animals ; Blinking ; Electromyography ; Eye Movements ; Eyelids ; innervation ; Facial Paralysis ; Male ; Muscle, Skeletal ; physiology ; Rabbits
2.Changes in the sonographic appearance of the endometrium after different premenopausal tamoxifen therapies.
Li-Xue ZHOU ; Jun ZHU ; Hong DING ; Cai-Xia JIA ; Shu-Juan XUE ; Rui-Ke PAN
Journal of Southern Medical University 2007;27(8):1227-1229
OBJECTIVETo assess the effect of different schemes of premenopausal tamoxifen therapy on the endometrium.
METHODSTotally 109 normal premenopausal women positive for high-risk factors of breast cancer were divided into two groups, namely periodic and consecutive tamoxifen treatment groups. Endometrial thickness as examined by vaginal sonography was assessed in relation to duration of tamoxifen use and time from discontinuation of the drug.
RESULTSAfter one year of tamoxifen use, the mean endometrial thickness in periodic treatment group was 6.5-/+1.4 mm, and 10.2-/+2.0 mm in consecutive treatment group. Endometrial thickness increased with the duration of tamoxifen use at the rate of 0.51 mm/year in the periodic treatment group, and 0.73 mm/year in consecutive treatment group. After discontinuation of tamoxifen, the endometrial thickness in the former group decreased by 1.29 mm/year, and by 1.33 mm/year in the latter.
CONCLUSIONSEndometrial hyperplasia is obviously milder in premenopausal women receiving periodic tamoxifen treatment who are at risk for breast cancer than that in women with consecutive treatment. After discontinuation of the drug, the endometrial thickness decreases at a roughly equal slow rate in the two groups.
Adult ; Breast Neoplasms ; drug therapy ; Drug Administration Schedule ; Endometrium ; anatomy & histology ; diagnostic imaging ; drug effects ; Female ; Humans ; Premenopause ; drug effects ; Risk ; Tamoxifen ; administration & dosage ; pharmacology ; therapeutic use ; Time Factors ; Ultrasonography
3.Clinical observation on effect of danzhi xiaoyao powder in treating depression.
He-Chun LUO ; Rui-Qin QIAN ; Xue-Ying ZHAO ; Juan BI ; Hongling XIN ; Xuezhu JIANG ; Ke XU ; Shaoxiao YAN
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(3):212-214
OBJECTIVETo observe the effect and side effect of Danzhi Xiaoyao powder (DXP) in treating depression.
METHODSA randomized controlled and double-blinded study was conducted in 63 cases of depression by divided them into the western medicine group (WMG, 31 cases) treated with maprotiline, and the Chinese medicine group (CMG, 32 cases) treated with DXP. The effect of therapy was evaluated before and at the 2nd, 4th and 6th week of the treatment with Hamilton's depressive scale (HAMD), self-rating depression scale (SDS), self-rating anxiety scale (SAS) and the scale for TCM syndrome and symptom differentiation (TCM-SSD), and the side-effect of therapy was assessed with Asberg side-effect scale as well.
RESULTSThere was no significant difference between the two groups in scores of HAMD, SDS, SAS, and TCM-SSD. The markedly effective rate in CMG was 84% and in WMG 87%, showed no significance between them (P > 0.05). The scores of HAMD, SDS and SAS of both groups were remarkably lowered after therapy (P < 0.05). However, the score of Asberg in CMG was lower than that in WMG (P < 0.05).
CONCLUSIONDXP shows the effect equivalent to that of maprotiline, but with obviously less side-effect.
Adult ; Antidepressive Agents ; therapeutic use ; Depressive Disorder ; drug therapy ; Double-Blind Method ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Male ; Maprotiline ; therapeutic use ; Middle Aged ; Phytotherapy ; Psychiatric Status Rating Scales
4.Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura.
Ying ZHU ; Yang DONG ; Da-Liang XU ; Jia-Yun JIANG ; Lin WU ; Rui-Juan KE ; Shao-Han FANG ; Yin PENG
Chinese Journal of Contemporary Pediatrics 2018;20(5):378-382
OBJECTIVETo study the clinical effect and mechanism of hemoperfusion (HP) in the treatment of children with severe abdominal Henoch-Schönlein purpura (HSP).
METHODSA total of 24 children with severe abdominal HSP were divided into two groups: conventional treatment and HP (n=12 each). Ten healthy children who underwent physical examination were enrolled as the control group. Before and after treatment, chemiluminescence was used to measure the serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α); thiobarbituric acid colorimetry was used to measure the plasma level of malondialdehyde (MDA); the hydroxylamine method was used to measure the plasma level of superoxide dismutase (SOD); chemical colorimetry was used to measure the plasma level of total anti-oxidant capability (T-AOC).
RESULTSCompared with the control group, the conventional treatment and HP groups had significantly higher IL-6, TNF-α, and MDA levels and significantly lower SOD and T-AOC levels before treatment (P<0.05), but there were no significant differences between the conventional treatment and HP groups (P>0.05). After treatment, the conventional treatment and HP groups had significant reductions in IL-6, TNF-α, and MDA levels and significant increases in SOD and T-AOC levels (P<0.05). The HP group had significantly greater changes than the conventional treatment group; however, there were still significant differences in these indices between the HP and control groups (P<0.05). Compared with the HP group, the conventional treatment group had a significantly lower percentage of children with disappearance of digestive tract symptoms at 4 days after treatment and significantly longer time to disappearance of rash and digestive tract symptoms (P<0.05). Compared with the conventional treatment group, the HP group had a significantly lower amount of glucocorticoid used during treatment and a significantly lower percentage of children who experienced hematuria and/or proteinuria within 6 months of the disease course (P<0.05). There were no significant differences between the two groups in length of hospital stay and recurrence rates of rash and abdominal pain within 6 months of the disease course.
CONCLUSIONSHP can reduce the amount of glucocorticoid used during treatment and the incidence rate of kidney injury in children with severe abdominal HSP, possibly by eliminating IL-6, TNF-α, and MDA.
Adolescent ; Child ; Child, Preschool ; Female ; Hemoperfusion ; Humans ; Interleukin-6 ; blood ; Male ; Malondialdehyde ; blood ; Purpura, Schoenlein-Henoch ; metabolism ; therapy ; Superoxide Dismutase ; blood ; Tumor Necrosis Factor-alpha ; blood
5.Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.
Bing-Lei ZHANG ; Jian ZHOU ; Tian-Xi LYU ; Rui-Rui GUI ; Ying-Ling ZU ; Feng-Kuan YU ; Hui-Fang ZHAO ; Zhen LI ; Juan WANG ; Yan-Li ZHANG ; Wen-Lin ZHANG ; Yue-Wen FU ; Xu-Dong WEI ; Bai-Jun FANG ; Yu-Fu LI ; Ke-Shu ZHOU ; Yong-Ping SONG
Chinese Medical Journal 2019;132(7):860-864
Adolescent
;
Busulfan
;
therapeutic use
;
Child
;
Child, Preschool
;
Cyclophosphamide
;
therapeutic use
;
Cyclosporine
;
therapeutic use
;
Female
;
Hematopoietic Stem Cell Transplantation
;
methods
;
Humans
;
Infant
;
Leukemia
;
drug therapy
;
mortality
;
therapy
;
Leukemia, Myeloid, Acute
;
drug therapy
;
mortality
;
therapy
;
Male
;
Mycophenolic Acid
;
therapeutic use
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
drug therapy
;
mortality
;
therapy
;
Retrospective Studies
;
Treatment Outcome
6.Correlation between the expression of thrombospondin-1 and neovascularization in mucoepidermoid carcinoma.
Sen YANG ; Xiao-yi WANG ; Li-juan GUO ; Xiu-fa TANG ; Qing-hong GAO ; Ming XUAN ; Qiang ZHANG ; Ke TAN ; Yu-ming WEN ; Chang-mei WANG ; Rui-an XU ; Yu-tang CAO
Chinese Medical Journal 2008;121(19):1875-1881
BACKGROUNDResearchers have recently demonstrated that thrombospondin-1 (TSP-1) has an important function in regulating neovascularization. Whether it inhibits or accelerates neovascularization, however, is still controversial. We found few reports about the correlation between TSP-1 and vascularization in mucoepidermoid carcinoma. In this research, the distribution and expression of TSP-1 in mucoepidermoid carcinoma were investigated. We also analyzed (1) the correlation between the expression of TSP-1 and microvessel density (MVD), as an indicator of neovascularization activity, and (2) the effect of TSP-1 on neovascularization and tumor growth in the subcutaneous xenotransplanted model of mucoepidermoid carcinoma.
METHOD(1) The sites and intensity of expression of TSP-1 and the MVD were analyzed in 45 cases of mucoepidermoid carcinoma after surgery by the method of streptavidin-peroxidase (SP) immunohistochemistry; and (2) recombinant human thrombospondin-1 (rhTSP-1) was injected twice a week for five consecutive weeks around the tumor in the subcutaneous xenotransplanted tumor model of mucoepidermoid carcinoma in nude mice. Each week, the tumor size was measured, in order to draw the growth curve of the xenotransplanted tumor model of mucoepidermoid carcinoma, and MVD was measured.
RESULTS(1) The positive expression of TSP-1 protein was 57.78% (26/45). Most positive staining for TSP-1 was found in the cytoplasm of the cancer cells, while some staining occurred in the extracellular matrix. The mean MVD in 45 cases of mucoepidermoid carcinoma was 58.17 +/- 19.77 per 100 visual fields. Tumors with a high expression of TSP-1 showed a low MVD value, and the TSP-1 immunocompetence and microvessel density showed a significant negative correlation (r(s) = -0.947, P < 0.001). (2) The xenotransplanted tumors with the injection doses of 1.25, 0.75 and 0.25 microg/ml respectively were 36.97%, 53.36% and 73.61% of the size of the control group ((451 +/- 92), (651 +/- 113), (898 +/- 86) and (1220 +/- 157) mm(3) respectively, F = 53.167, P < 0.001), and their weights were respectively 35.14%, 51.35% and 70.27% of the control group ((1.3 +/- 0.5), (1.9 +/- 0.5), (2.6 +/- 0.3), and (3.7 +/- 0.7) g respectively, F = 62.669, P < 0.001). Their MVDs were 25.00%, 45.93%, and 72.20% respectively of the control group and concentration dependent (15.43 +/- 3.45, 28.35 +/- 4.24, 44.57 +/- 3.35 and 61.73 +/- 5.43 per 100 visual fields respectively, F = 54.582, P < 0.001).
CONCLUSIONSThe TSP-1 has a higher expression in mucoepidermoid carcinoma and the expression has a significant negative correlation with neovascularization. The TSP-1 inhibits neovascularization and tumor growth, and it might be a new biological therapy for treatment of patients with mucoepidermoid carcinoma.
Adult ; Aged ; Animals ; Carcinoma, Mucoepidermoid ; blood supply ; chemistry ; pathology ; Female ; Humans ; Male ; Mice ; Middle Aged ; Neoplasm Transplantation ; Neovascularization, Pathologic ; pathology ; Recombinant Proteins ; pharmacology ; Thrombospondin 1 ; analysis ; pharmacology ; Transplantation, Heterologous
7. The reversal effect of albiflorin on multidrug resistance of human ovarian cancer and its mechanism
Li HAN ; Xiao-Juan GUO ; Rui-Juan DU ; Yi CHEN ; Qing-Lin FEI ; Ke-Lei GUO ; Hua BIAN ; Li HAN ; Rui-Juan DU ; Ke-Lei GUO ; Hua BIAN
Chinese Pharmacological Bulletin 2023;39(2):268-274
Aim To study the reversal effect of albiflorin(AL)on multidrug resistance of human ovarian cancer and the potential mechanism. Methods The drug resistance reversal effect of AL on SKOV3/DDP cells was detected by CCK-8 kit,and the effect of AL on P-glycoprotein(P-gp)function was detected by flow cytometry. The effects of AL on MYC,WWP1 and ABCB1 in SKOV3/DDP cells were detected by RT-qPCR and Western blot. The MYC-knockdown SKOV3/DDP cell line was constructed by RNA interference technology,and its drug resistance,P-gp function and related gene and protein expression changes were investigated. Results AL had a drug resistance reversal effect on SKOV3/DDP cells and a concentration-dependent inhibitory effect on P-gp function. The inhibitory effects of AL 25,50 and 100 μmol·L-1 on ABCB1/P-gp,MYC and WWP1 were gradually enhanced. The inhibitory effect of MYCi975,a MYC inhibitor,on ABCB1/P-gp,MYC and WWP1 was stronger than or equivalent to that of AL 100 μmol·L-1 group. After knockdown of MYC in SKOV3/DDP cells,cell drug resistance,P-gp function,and related gene and protein expression were inhibited. Conclusions The drug resistance reversal effect of AL on SKOV3/DDP cells may be related to the inhibition of P-gp function and the expression of ABCB1/P-gp,MYC and WWP1,which provides an experiment base for the development of AL as a drug resistance reversal agent for the clinical treatment of ovarian cancer.
8.Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies.
Fei ZHANG ; Xiao-Fei SUN ; Yong-Qiang LI ; Zi-Jun ZHEN ; Hai-Xia ZHENG ; Jia ZHU ; Qi-Jing WANG ; Su-Ying LU ; Jia HE ; Juan WANG ; Ke PAN ; Rui-Qing CAI ; Yan CHEN ; De-Sheng WENG ; Fei-Fei SUN ; Jian-Chuan XIA
Chinese Journal of Cancer 2013;32(12):661-666
In vitro amplified human leukocyte antigen (HLA)-haploidentical donor immune cell infusion (HDICI) is not commonly used in children. Therefore, our study sought to evaluate its safety for treating childhood malignancies. Between September 2011 and September 2012, 12 patients with childhood malignancies underwent HDICI in Sun Yat-sen University Cancer Center. The median patient age was 5.1 years (range, 1.7-8.4 years). Of the 12 patients, 9 had high-risk neuroblastoma (NB) [7 showed complete response (CR), 1 showed partial response (PR), and 1 had progressive disease (PD) after multi-modal therapies], and 3 had Epstein-Barr virus (EBV)-positive lymphoproliferative disease (EBV-LPD). The 12 patients underwent a total of 92 HDICIs at a mean dose of 1.6×10(8) immune cells/kg body weight: 71 infusions with natural killer (NK) cells, 8 with cytokine-induced killer (CIK) cells, and 13 with cascade primed immune cells (CAPRIs); 83 infusions with immune cells from the mothers, whereas 9 with cells from the fathers. Twenty cases (21.7%) of fever, including 6 cases (6.5%) accompanied with chills and 1 (1.1%) with febrile convulsion, occurred during infusions and were alleviated after symptomatic treatments. Five cases (5.4%) of mild emotion changes were reported. No other adverse events occurred during and after the completion of HDIDIs. Neither acute nor chronic graft versus host disease (GVHD) was observed following HDICIs. After a median of 5.0 months (range, 1.0-11.5 months) of follow-up, the 2 NB patients with PR and PD developed PD during HDICIs. Of the other 7 NB patients in CR, 2 relapsed in the sixth month of HDICIs, and 5 maintained CR with disease-free survival (DFS) ranging from 4.5 to 11.5 months (median, 7.2 months). One EBV-LPD patient achieved PR, whereas 2 had stable disease (SD). Our results show that HDICI is a safe immunotherapy for childhood malignancies, thus warranting further studies.
Child
;
Child, Preschool
;
Cytokine-Induced Killer Cells
;
immunology
;
Epstein-Barr Virus Infections
;
therapy
;
Female
;
Follow-Up Studies
;
Graft vs Host Disease
;
etiology
;
Hematopoietic Stem Cell Transplantation
;
adverse effects
;
Humans
;
Immunotherapy, Adoptive
;
Infant
;
Killer Cells, Natural
;
immunology
;
Lymphoproliferative Disorders
;
therapy
;
virology
;
Male
;
Neuroblastoma
;
therapy
;
Transplantation, Homologous
;
Treatment Outcome
9.Preliminary molecular epidemiology of the Staphylococcus aureus in lower respiratory tract infections: a multicenter study in China.
De-Zhi LI ; Yu-Sheng CHEN ; Jing-Ping YANG ; Wei ZHANG ; Cheng-Ping HU ; Jia-Shu LI ; Lan MU ; Ying-Hui HU ; Rong GENG ; Ke HU ; Shao-Xi CAI ; Huan-Ying WAN ; Qiu-Yue WANG ; Li-Ping WEI ; Juan DU ; Qin YU ; Xiao-Ning ZHONG ; Rui-Qin WANG ; Jian-Jun MA ; Gui-Zhen TIAN ; Si-Qin WANG ; Zhan-Cheng GAO
Chinese Medical Journal 2011;124(5):687-692
BACKGROUNDStaphylococcus aureus (S. aureus) remains as an important microbial pathogen resulting in community and nosocomial acquired infections with significant morbidity and mortality. Few reports for S. aureus in lower respiratory tract infections (LRTIs) have been documented. The aim of this study was to explore the molecular epidemiology of S. aureus in LRTIs in China.
METHODSA multicenter study of the molecular epidemiology of S. aureus in LRTIs was conducted in 21 hospitals in Beijing, Shanghai and twelve other provinces from November 2007 to February 2009. All the collected S. aureus strains were classified as minimum inhibitory concentration (MIC), mecA gene, virulence genes Panton-Valentine Leukocidin (PVL) and γ-hemolysin (hlg), staphylococcal cassette chromosome mec (SCCmec) type, agr type, and Multilocus Sequence Typing (MLST).
RESULTSTotally, nine methicillin-sensitive S. aureus (MSSA) and 29 methicillin-resistant S. aureus (MRSA) strains were isolated after culture from a total of 2829 sputums or bronchoalveolar lavages. The majority of MRSA strains (22/29) had a MIC value of ≥ 512 µg/ml for cefoxitin. The mecA gene acting as the conservative gene was carried by all MRSA strains. PVL genes were detected in only one S. aureus strain (2.63%, 1/38). The hlg gene was detected in almost the all S. aureus (100% in MSSA and 96.56% in MRSA strains). About 75.86% of MRSA strains carried SCCmec III. Agr type 1 was predominant (78.95%) among the identified three agr types (agr types 1, 2, and 3). Totally, ten sequence type (ST) of S. aureus strains were detected. A new sequence type (ST1445) was found besides confirming ST239 as the major sequence type (60.53%). A dendrogram generated from our own MLST database showed all the bootstrap values ≤ 50%.
CONCLUSIONOur preliminary epidemiology data show SCCmec III, ST239 and agr type 1 of S. aureus as the predominant strains in LRTIs in Mainland of China.
Alleles ; Anti-Bacterial Agents ; therapeutic use ; China ; epidemiology ; Drug Resistance, Bacterial ; genetics ; Humans ; Microbial Sensitivity Tests ; Prospective Studies ; Respiratory Tract Infections ; epidemiology ; Staphylococcal Infections ; epidemiology ; Staphylococcus aureus ; drug effects ; pathogenicity
10.Drug-resistant genes carried by Acinetobacter baumanii isolated from patients with lower respiratory tract infection.
Ning DAI ; De-zhi LI ; Ji-chao CHEN ; Yu-sheng CHEN ; Rong GENG ; Ying-hui HU ; Jing-ping YANG ; Juan DU ; Cheng-ping HU ; Wei ZHANG ; Jia-shu LI ; Qin YU ; Huan-ying WAN ; Lan MU ; Xiao-ning ZHONG ; Li-ping WEI ; Jian-jun MA ; Qiu-yue WANG ; Ke HU ; Gui-zhen TIAN ; Shao-xi CAI ; Rui-qin WANG ; Bei HE ; Si-qin WANG ; Zhan-wei WANG ; Su-rui ZHAO ; Zhan-cheng GAO
Chinese Medical Journal 2010;123(18):2571-2575
BACKGROUNDAcinetobacter baumanii (A. baumanii ) remains an important microbial pathogen resulting in nosocomial acquired infections with significant morbidity and mortality. The mechanism by which nosocomial bacteria, like A. baumanii, attain multidrug resistance to antibiotics is of considerable interest. The aim in this study was to investigate the spread status of antibiotic resistance genes, such as multiple β-lactamase genes and aminoglycoside-modifying enzyme genes, from A. baumanii strains isolated from patients with lower respiratory tract infections (LRTIs).
METHODSTwo thousand six hundred and ninety-eight sputum or the bronchoalveolar lavage samples from inpatients with LRTIs were collected in 21 hospitals in the mainland of China from November 2007 to February 2009. All samples were routinely inoculated. The isolated bacterial strains and their susceptibility were analyzed via VITEK-2 expert system. Several kinds of antibiotic resistant genes were further differentiated via polymerase chain reaction and sequencing methods.
RESULTSTotally, 39 A. baumanii strains were isolated from 2698 sputum or bronchoalveolar lavage samples. There was not only a high resistant rate of the isolated A. baumanii strains to ampicillin and first- and second-generation cephalosporins (94.87%, 100% and 97.44%, respectively), but also to the third-generation cephalosporins (ceftriaxone at 92.31%, ceftazidine at 51.28%) and imipenem (43.59%) as well. The lowest antibiotic resistance rate of 20.51% was found to amikacin. The OXA-23 gene was identified in 17 strains of A. baumanii, and the AmpC gene in 23 strains. The TEM-1 gene was carried in 15 strains. PER-1 and SHV-2 genes were detected in two different strains. Aminoglycoside-modifying enzyme gene aac-3-Ia was found in 23 strains, and the aac-6'-Ib gene in 19 strains. aac-3-Ia and aac-6'-Ib genes hibernated in three A. baumanii strains that showed no drug-resistant phenotype.
CONCLUSIONSA. baumanii can carry multiple drug-resistant genes at the same time and result in multi-drug resistance. Aminoglycoside-modifying enzyme genes could be hibernating in aminoglycoside sensitive strains without expressing their phenotype.
Acinetobacter ; genetics ; metabolism ; pathogenicity ; Acinetobacter Infections ; microbiology ; Bacterial Proteins ; genetics ; Bronchoalveolar Lavage Fluid ; microbiology ; Drug Resistance, Multiple, Bacterial ; genetics ; Humans ; Microbial Sensitivity Tests ; Polymerase Chain Reaction ; Respiratory Tract Infections ; microbiology ; Sputum ; microbiology